68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label positron emission tomography/computed tomography (PET/CT) study to
investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-PRGD2 in lung
injury (LI) and pulmonary fibrosis (PF) patients. A single dose of nearly 111 MBq
68Ga-NOTA-PRGD2 (≤ 40 µg NOTA-PRGD2) will be intravenously injected into patients with LI/PF.
Visual and semiquantitative method will be used to assess the PET/CT images.